

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 7.97070586 |
| 2 | low-density lipoprotein particle clearance (GO:0034383) | 7.31172119 |
| 3 | N-acetylneuraminate metabolic process (GO:0006054) | 6.88561828 |
| 4 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 6.61412255 |
| 5 | protoporphyrinogen IX metabolic process (GO:0046501) | 6.36543639 |
| 6 | positive regulation of histone deacetylation (GO:0031065) | 6.32321379 |
| 7 | triglyceride catabolic process (GO:0019433) | 6.06366418 |
| 8 | regulation of sequestering of triglyceride (GO:0010889) | 5.97802700 |
| 9 | acylglycerol catabolic process (GO:0046464) | 5.54716838 |
| 10 | neutral lipid catabolic process (GO:0046461) | 5.54716838 |
| 11 | cellular extravasation (GO:0045123) | 5.30884394 |
| 12 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 5.25500090 |
| 13 | fatty acid homeostasis (GO:0055089) | 4.81392729 |
| 14 | centriole replication (GO:0007099) | 4.80451854 |
| 15 | negative regulation of phagocytosis (GO:0050765) | 4.62175770 |
| 16 | cellular response to cadmium ion (GO:0071276) | 4.59513450 |
| 17 | plasma lipoprotein particle clearance (GO:0034381) | 4.49418434 |
| 18 | positive regulation of protein deacetylation (GO:0090312) | 4.46704667 |
| 19 | amino sugar catabolic process (GO:0046348) | 4.42900472 |
| 20 | regulation of MHC class II biosynthetic process (GO:0045346) | 4.39700892 |
| 21 | polyol transport (GO:0015791) | 4.37428421 |
| 22 | diacylglycerol metabolic process (GO:0046339) | 4.33839920 |
| 23 | purine deoxyribonucleotide catabolic process (GO:0009155) | 4.22913308 |
| 24 | low-density lipoprotein particle remodeling (GO:0034374) | 4.22798660 |
| 25 | response to folic acid (GO:0051593) | 4.12950894 |
| 26 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.08478072 |
| 27 | L-phenylalanine catabolic process (GO:0006559) | 4.08478072 |
| 28 | positive regulation of lipid storage (GO:0010884) | 4.08004013 |
| 29 | glycerolipid catabolic process (GO:0046503) | 3.97536179 |
| 30 | reactive oxygen species biosynthetic process (GO:1903409) | 3.92070992 |
| 31 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.88455191 |
| 32 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.88455191 |
| 33 | L-phenylalanine metabolic process (GO:0006558) | 3.85955804 |
| 34 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.85955804 |
| 35 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.85599903 |
| 36 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.85051096 |
| 37 | base-excision repair, AP site formation (GO:0006285) | 3.84884117 |
| 38 | thalamus development (GO:0021794) | 3.83620706 |
| 39 | angiotensin maturation (GO:0002003) | 3.77147550 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 3.74176233 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 3.74176233 |
| 42 | macromolecular complex remodeling (GO:0034367) | 3.74176233 |
| 43 | alpha-linolenic acid metabolic process (GO:0036109) | 3.70831452 |
| 44 | acylglycerol homeostasis (GO:0055090) | 3.70818492 |
| 45 | triglyceride homeostasis (GO:0070328) | 3.70818492 |
| 46 | NADH metabolic process (GO:0006734) | 3.69442697 |
| 47 | macrophage chemotaxis (GO:0048246) | 3.68860239 |
| 48 | ethanol oxidation (GO:0006069) | 3.68563092 |
| 49 | N-acetylglucosamine metabolic process (GO:0006044) | 3.64901558 |
| 50 | regulation of glycolytic process (GO:0006110) | 3.63836001 |
| 51 | transcytosis (GO:0045056) | 3.62580893 |
| 52 | heme biosynthetic process (GO:0006783) | 3.59020056 |
| 53 | cytokinetic process (GO:0032506) | 3.55517061 |
| 54 | negative regulation of growth of symbiont in host (GO:0044130) | 3.55307929 |
| 55 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.55307929 |
| 56 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.55307929 |
| 57 | regulation of growth of symbiont in host (GO:0044126) | 3.55307929 |
| 58 | triglyceride biosynthetic process (GO:0019432) | 3.53444671 |
| 59 | regulation of chemokine biosynthetic process (GO:0045073) | 3.47816212 |
| 60 | ethanol metabolic process (GO:0006067) | 3.43974666 |
| 61 | regulation of cholesterol storage (GO:0010885) | 3.43823925 |
| 62 | positive regulation of glycolytic process (GO:0045821) | 3.43362656 |
| 63 | acylglycerol biosynthetic process (GO:0046463) | 3.43072003 |
| 64 | neutral lipid biosynthetic process (GO:0046460) | 3.43072003 |
| 65 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.38775421 |
| 66 | phospholipid homeostasis (GO:0055091) | 3.38080620 |
| 67 | negative regulation of fibrinolysis (GO:0051918) | 3.37079970 |
| 68 | fatty acid transmembrane transport (GO:1902001) | 3.33153206 |
| 69 | lipid storage (GO:0019915) | 3.30604115 |
| 70 | triglyceride metabolic process (GO:0006641) | 3.30249842 |
| 71 | primary alcohol metabolic process (GO:0034308) | 3.24148474 |
| 72 | centriole assembly (GO:0098534) | 3.14892889 |
| 73 | regulation of triglyceride catabolic process (GO:0010896) | 3.14686510 |
| 74 | negative regulation of interleukin-2 production (GO:0032703) | 3.14620464 |
| 75 | lipid particle organization (GO:0034389) | 3.11502122 |
| 76 | acylglycerol metabolic process (GO:0006639) | 3.10290920 |
| 77 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.08122201 |
| 78 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.08122201 |
| 79 | microglial cell activation (GO:0001774) | 3.07087748 |
| 80 | amino-acid betaine metabolic process (GO:0006577) | 3.06883392 |
| 81 | neutral lipid metabolic process (GO:0006638) | 3.05417208 |
| 82 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.03880060 |
| 83 | primary alcohol catabolic process (GO:0034310) | 3.03016250 |
| 84 | carnitine shuttle (GO:0006853) | 3.01669700 |
| 85 | brown fat cell differentiation (GO:0050873) | 3.00782972 |
| 86 | regulation of histone deacetylation (GO:0031063) | 3.00080432 |
| 87 | cholesterol homeostasis (GO:0042632) | 2.99893892 |
| 88 | acetyl-CoA metabolic process (GO:0006084) | 2.99891461 |
| 89 | regulation of fatty acid transport (GO:2000191) | 2.99384912 |
| 90 | glial cell migration (GO:0008347) | 2.99258500 |
| 91 | biotin metabolic process (GO:0006768) | 2.96999615 |
| 92 | response to phenylpropanoid (GO:0080184) | 2.96994352 |
| 93 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.94528823 |
| 94 | oxaloacetate metabolic process (GO:0006107) | 2.92999673 |
| 95 | sterol homeostasis (GO:0055092) | 2.92588020 |
| 96 | glycerol metabolic process (GO:0006071) | 2.90831421 |
| 97 | thioester metabolic process (GO:0035383) | 2.90811376 |
| 98 | acyl-CoA metabolic process (GO:0006637) | 2.90811376 |
| 99 | regulation of protein import into nucleus, translocation (GO:0033158) | 2.90151869 |
| 100 | heme metabolic process (GO:0042168) | 2.89355536 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 9.45999559 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.49153720 |
| 3 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 4.03683567 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.60092000 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.39090363 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.35023597 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.20505101 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.07299753 |
| 9 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.03198701 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.60843302 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.39713809 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.18285117 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.17151333 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.16529607 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.99884690 |
| 16 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.72601199 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.65844716 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.58217522 |
| 19 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.55603011 |
| 20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54999126 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.50769826 |
| 22 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48545739 |
| 23 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.42684399 |
| 24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.40081033 |
| 25 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.39036868 |
| 26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.38123550 |
| 27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.31997650 |
| 28 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26110346 |
| 29 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.25586899 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23649307 |
| 31 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.22435955 |
| 32 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.22406539 |
| 33 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.18348989 |
| 34 | RXR_22108803_ChIP-Seq_LS180_Human | 1.17230624 |
| 35 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.16619277 |
| 36 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.14221025 |
| 37 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.11628886 |
| 38 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.11628886 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10723883 |
| 40 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.10396303 |
| 41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09974874 |
| 42 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.08299831 |
| 43 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.06117117 |
| 44 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.05576725 |
| 45 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.02964415 |
| 46 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.01256939 |
| 47 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00349410 |
| 48 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.99719725 |
| 49 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.99463458 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97471537 |
| 51 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96984364 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.96242240 |
| 53 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.95483074 |
| 54 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.94577356 |
| 55 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.94329360 |
| 56 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.93677283 |
| 57 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93619451 |
| 58 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.93051090 |
| 59 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.92999472 |
| 60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.92660823 |
| 61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92520599 |
| 62 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88927586 |
| 63 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.88326257 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88041983 |
| 65 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.86906911 |
| 66 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83692007 |
| 67 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.82993591 |
| 68 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.81204981 |
| 69 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.81008540 |
| 70 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.79973743 |
| 71 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.79435849 |
| 72 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.79210889 |
| 73 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.77716942 |
| 74 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.77716942 |
| 75 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.77514085 |
| 76 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.77248413 |
| 77 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.76087723 |
| 78 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.74566726 |
| 79 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.73213223 |
| 80 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.73151710 |
| 81 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.73107025 |
| 82 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.72783131 |
| 83 | SA1_27219007_Chip-Seq_Bcells_Human | 0.72541676 |
| 84 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.72375995 |
| 85 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.72312940 |
| 86 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.72050449 |
| 87 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.71610073 |
| 88 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.71092756 |
| 89 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.70674910 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70574141 |
| 91 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70050517 |
| 92 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.68301733 |
| 93 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.67712009 |
| 94 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.67441315 |
| 95 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.66298286 |
| 96 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.65963130 |
| 97 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.65889100 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.65553145 |
| 99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.64745756 |
| 100 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.64654510 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 8.33348429 |
| 2 | MP0005083_abnormal_biliary_tract | 6.07132211 |
| 3 | MP0005365_abnormal_bile_salt | 4.44652392 |
| 4 | MP0005666_abnormal_adipose_tissue | 4.02467198 |
| 5 | MP0005375_adipose_tissue_phenotype | 3.62319103 |
| 6 | MP0004130_abnormal_muscle_cell | 3.40628938 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.37542315 |
| 8 | MP0002971_abnormal_brown_adipose | 3.23421851 |
| 9 | MP0000003_abnormal_adipose_tissue | 3.16312388 |
| 10 | MP0008961_abnormal_basal_metabolism | 3.04754897 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 3.03079094 |
| 12 | MP0003252_abnormal_bile_duct | 2.85463749 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.76855961 |
| 14 | MP0009115_abnormal_fat_cell | 2.65565483 |
| 15 | MP0002970_abnormal_white_adipose | 2.13979612 |
| 16 | MP0005334_abnormal_fat_pad | 2.13180298 |
| 17 | MP0003959_abnormal_lean_body | 2.01602271 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 1.99144076 |
| 19 | MP0004185_abnormal_adipocyte_glucose | 1.91867843 |
| 20 | MP0005167_abnormal_blood-brain_barrier | 1.91634441 |
| 21 | MP0003868_abnormal_feces_composition | 1.89483696 |
| 22 | MP0000751_myopathy | 1.88546383 |
| 23 | MP0005448_abnormal_energy_balance | 1.70761345 |
| 24 | MP0006138_congestive_heart_failure | 1.68431533 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.65268086 |
| 26 | MP0003195_calcinosis | 1.57886567 |
| 27 | MP0005360_urolithiasis | 1.55591902 |
| 28 | MP0004043_abnormal_pH_regulation | 1.54956392 |
| 29 | MP0003828_pulmonary_edema | 1.51301532 |
| 30 | MP0010368_abnormal_lymphatic_system | 1.50908213 |
| 31 | MP0003011_delayed_dark_adaptation | 1.45872156 |
| 32 | MP0005535_abnormal_body_temperature | 1.41408424 |
| 33 | MP0002876_abnormal_thyroid_physiology | 1.37041235 |
| 34 | MP0004084_abnormal_cardiac_muscle | 1.30837977 |
| 35 | MP0002837_dystrophic_cardiac_calcinosis | 1.27863263 |
| 36 | MP0000343_altered_response_to | 1.26785010 |
| 37 | MP0004036_abnormal_muscle_relaxation | 1.22975443 |
| 38 | MP0005451_abnormal_body_composition | 1.22106488 |
| 39 | MP0004272_abnormal_basement_membrane | 1.20361733 |
| 40 | MP0000013_abnormal_adipose_tissue | 1.15440327 |
| 41 | MP0004087_abnormal_muscle_fiber | 1.14782793 |
| 42 | MP0001661_extended_life_span | 1.13846721 |
| 43 | MP0002078_abnormal_glucose_homeostasis | 1.13443186 |
| 44 | MP0001544_abnormal_cardiovascular_syste | 1.11908502 |
| 45 | MP0005385_cardiovascular_system_phenoty | 1.11908502 |
| 46 | MP0005452_abnormal_adipose_tissue | 1.11016122 |
| 47 | MP0004215_abnormal_myocardial_fiber | 1.07004187 |
| 48 | MP0009643_abnormal_urine_homeostasis | 1.04912916 |
| 49 | MP0003186_abnormal_redox_activity | 1.04579818 |
| 50 | MP0005330_cardiomyopathy | 1.04457342 |
| 51 | MP0003690_abnormal_glial_cell | 1.04065405 |
| 52 | MP0005266_abnormal_metabolism | 1.03393482 |
| 53 | MP0000609_abnormal_liver_physiology | 1.01083659 |
| 54 | MP0002909_abnormal_adrenal_gland | 0.99053591 |
| 55 | MP0006036_abnormal_mitochondrial_physio | 0.98756676 |
| 56 | MP0000749_muscle_degeneration | 0.97084678 |
| 57 | MP0002972_abnormal_cardiac_muscle | 0.95240853 |
| 58 | MP0001502_abnormal_circadian_rhythm | 0.94190481 |
| 59 | MP0003191_abnormal_cellular_cholesterol | 0.93703144 |
| 60 | MP0008775_abnormal_heart_ventricle | 0.93309372 |
| 61 | MP0000249_abnormal_blood_vessel | 0.90555885 |
| 62 | MP0008058_abnormal_DNA_repair | 0.89485607 |
| 63 | MP0002127_abnormal_cardiovascular_syste | 0.88703697 |
| 64 | MP0005164_abnormal_response_to | 0.87940083 |
| 65 | MP0005332_abnormal_amino_acid | 0.87458090 |
| 66 | MP0002295_abnormal_pulmonary_circulatio | 0.87286086 |
| 67 | MP0003566_abnormal_cell_adhesion | 0.86428855 |
| 68 | MP0000759_abnormal_skeletal_muscle | 0.85950833 |
| 69 | MP0003950_abnormal_plasma_membrane | 0.85585757 |
| 70 | MP0008438_abnormal_cutaneous_collagen | 0.83509698 |
| 71 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82260579 |
| 72 | MP0005620_abnormal_muscle_contractility | 0.79854054 |
| 73 | MP0009840_abnormal_foam_cell | 0.79533719 |
| 74 | MP0002269_muscular_atrophy | 0.78044221 |
| 75 | MP0000767_abnormal_smooth_muscle | 0.77228288 |
| 76 | MP0002108_abnormal_muscle_morphology | 0.75474014 |
| 77 | MP0002933_joint_inflammation | 0.73595585 |
| 78 | MP0003123_paternal_imprinting | 0.71710485 |
| 79 | MP0004484_altered_response_of | 0.71085698 |
| 80 | MP0001879_abnormal_lymphatic_vessel | 0.69124910 |
| 81 | MP0002106_abnormal_muscle_physiology | 0.69089498 |
| 82 | MP0000598_abnormal_liver_morphology | 0.68944087 |
| 83 | MP0010630_abnormal_cardiac_muscle | 0.66863267 |
| 84 | MP0005369_muscle_phenotype | 0.65639107 |
| 85 | MP0003953_abnormal_hormone_level | 0.63871624 |
| 86 | MP0003948_abnormal_gas_homeostasis | 0.63622325 |
| 87 | MP0004019_abnormal_vitamin_homeostasis | 0.61040154 |
| 88 | MP0003724_increased_susceptibility_to | 0.60779684 |
| 89 | MP0009780_abnormal_chondrocyte_physiolo | 0.60362484 |
| 90 | MP0005376_homeostasis/metabolism_phenot | 0.56857356 |
| 91 | MP0008872_abnormal_physiological_respon | 0.55646202 |
| 92 | MP0005367_renal/urinary_system_phenotyp | 0.52135334 |
| 93 | MP0000516_abnormal_urinary_system | 0.52135334 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 0.49542004 |
| 95 | MP0004885_abnormal_endolymph | 0.48395280 |
| 96 | MP0009384_cardiac_valve_regurgitation | 0.47553705 |
| 97 | MP0005647_abnormal_sex_gland | 0.46088372 |
| 98 | MP0000230_abnormal_systemic_arterial | 0.45999371 |
| 99 | MP0003638_abnormal_response/metabolism_ | 0.45755634 |
| 100 | MP0005595_abnormal_vascular_smooth | 0.45205659 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperlipoproteinemia (HP:0010980) | 5.46832967 |
| 2 | Epidermoid cyst (HP:0200040) | 4.75818254 |
| 3 | Xanthomatosis (HP:0000991) | 4.68526368 |
| 4 | Hypertriglyceridemia (HP:0002155) | 4.29219700 |
| 5 | Increased muscle lipid content (HP:0009058) | 4.17543206 |
| 6 | Deep venous thrombosis (HP:0002625) | 4.13003524 |
| 7 | Oligomenorrhea (HP:0000876) | 4.10963283 |
| 8 | Acanthosis nigricans (HP:0000956) | 4.01504562 |
| 9 | Complement deficiency (HP:0004431) | 3.96351104 |
| 10 | Skin nodule (HP:0200036) | 3.82829972 |
| 11 | Rhabdomyolysis (HP:0003201) | 3.78587542 |
| 12 | Hypercholesterolemia (HP:0003124) | 3.77960047 |
| 13 | Increased serum pyruvate (HP:0003542) | 3.76928653 |
| 14 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.72611820 |
| 15 | Myoglobinuria (HP:0002913) | 3.50036166 |
| 16 | Hemorrhage of the eye (HP:0011885) | 3.49780090 |
| 17 | Increased variability in muscle fiber diameter (HP:0003557) | 3.47052486 |
| 18 | Back pain (HP:0003418) | 3.43701913 |
| 19 | Abnormality of complement system (HP:0005339) | 3.39712579 |
| 20 | Joint hemorrhage (HP:0005261) | 3.38067780 |
| 21 | Abnormality of glycolysis (HP:0004366) | 3.31899133 |
| 22 | Protrusio acetabuli (HP:0003179) | 3.25536571 |
| 23 | Prolonged partial thromboplastin time (HP:0003645) | 3.20133027 |
| 24 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.18830168 |
| 25 | Myocardial infarction (HP:0001658) | 3.16466312 |
| 26 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.04167337 |
| 27 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.97887074 |
| 28 | Muscle fiber splitting (HP:0003555) | 2.92300370 |
| 29 | Asymmetric septal hypertrophy (HP:0001670) | 2.87807337 |
| 30 | Increased intramyocellular lipid droplets (HP:0012240) | 2.85706830 |
| 31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.83288237 |
| 32 | Difficulty running (HP:0009046) | 2.81901874 |
| 33 | Lipoatrophy (HP:0100578) | 2.80308076 |
| 34 | Esophageal varix (HP:0002040) | 2.80276167 |
| 35 | Insulin resistance (HP:0000855) | 2.71998816 |
| 36 | Infantile muscular hypotonia (HP:0008947) | 2.68515493 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.64302712 |
| 38 | Renal Fanconi syndrome (HP:0001994) | 2.59388320 |
| 39 | Increased connective tissue (HP:0009025) | 2.58328927 |
| 40 | Exercise-induced myalgia (HP:0003738) | 2.47920887 |
| 41 | Mesangial abnormality (HP:0001966) | 2.45562250 |
| 42 | Hyporeflexia of lower limbs (HP:0002600) | 2.44946040 |
| 43 | Systemic lupus erythematosus (HP:0002725) | 2.41249245 |
| 44 | Generalized hyperpigmentation (HP:0007440) | 2.38580806 |
| 45 | Sudden death (HP:0001699) | 2.38160011 |
| 46 | Adactyly (HP:0009776) | 2.28212999 |
| 47 | Pigmentary retinal degeneration (HP:0001146) | 2.26320948 |
| 48 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.22311482 |
| 49 | Dilated cardiomyopathy (HP:0001644) | 2.22067247 |
| 50 | Retinal atrophy (HP:0001105) | 2.21231227 |
| 51 | Porencephaly (HP:0002132) | 2.18839136 |
| 52 | Abnormality of the prostate (HP:0008775) | 2.15667739 |
| 53 | Neck muscle weakness (HP:0000467) | 2.15099768 |
| 54 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.14883943 |
| 55 | Abnormality of alanine metabolism (HP:0010916) | 2.14883943 |
| 56 | Hyperalaninemia (HP:0003348) | 2.14883943 |
| 57 | Spinal rigidity (HP:0003306) | 2.13168869 |
| 58 | Nausea (HP:0002018) | 2.09445375 |
| 59 | Mitral stenosis (HP:0001718) | 2.08967853 |
| 60 | Tubulointerstitial fibrosis (HP:0005576) | 2.07678118 |
| 61 | Absent hand (HP:0004050) | 2.06944066 |
| 62 | Hyperkalemia (HP:0002153) | 2.06311924 |
| 63 | Thin skin (HP:0000963) | 2.01852324 |
| 64 | Pancreatitis (HP:0001733) | 2.01470399 |
| 65 | Type 1 muscle fiber predominance (HP:0003803) | 1.98441189 |
| 66 | Increased hepatocellular lipid droplets (HP:0006565) | 1.96304007 |
| 67 | Hepatosplenomegaly (HP:0001433) | 1.96063256 |
| 68 | Exertional dyspnea (HP:0002875) | 1.95909576 |
| 69 | Glomerulonephritis (HP:0000099) | 1.94880472 |
| 70 | Hypobetalipoproteinemia (HP:0003563) | 1.93881626 |
| 71 | Cutaneous photosensitivity (HP:0000992) | 1.93764973 |
| 72 | Vertebral compression fractures (HP:0002953) | 1.93710732 |
| 73 | Lipid accumulation in hepatocytes (HP:0006561) | 1.92344708 |
| 74 | Thrombophlebitis (HP:0004418) | 1.89359779 |
| 75 | Abnormality of chloride homeostasis (HP:0011422) | 1.88036430 |
| 76 | Dicarboxylic aciduria (HP:0003215) | 1.87776676 |
| 77 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.87776676 |
| 78 | Bundle branch block (HP:0011710) | 1.86960080 |
| 79 | Atrioventricular block (HP:0001678) | 1.86860187 |
| 80 | Delayed CNS myelination (HP:0002188) | 1.85478121 |
| 81 | Abnormality of the common coagulation pathway (HP:0010990) | 1.81818580 |
| 82 | Menorrhagia (HP:0000132) | 1.80152634 |
| 83 | Portal hypertension (HP:0001409) | 1.79996756 |
| 84 | Fat malabsorption (HP:0002630) | 1.79823614 |
| 85 | Increased mean platelet volume (HP:0011877) | 1.79398242 |
| 86 | Psychosis (HP:0000709) | 1.77950332 |
| 87 | Coronal craniosynostosis (HP:0004440) | 1.77855906 |
| 88 | Abnormality of the intrinsic pathway (HP:0010989) | 1.77229251 |
| 89 | Skull defect (HP:0001362) | 1.76829554 |
| 90 | Steatorrhea (HP:0002570) | 1.76757752 |
| 91 | Abnormal atrioventricular conduction (HP:0005150) | 1.75208132 |
| 92 | Hyperphosphaturia (HP:0003109) | 1.74759148 |
| 93 | Glycosuria (HP:0003076) | 1.74585775 |
| 94 | Abnormality of urine glucose concentration (HP:0011016) | 1.74585775 |
| 95 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.73998700 |
| 96 | Abnormality of the calf musculature (HP:0001430) | 1.73667895 |
| 97 | Abnormality of vitamin metabolism (HP:0100508) | 1.73658602 |
| 98 | Hypolipoproteinemia (HP:0010981) | 1.73652199 |
| 99 | Prominent supraorbital ridges (HP:0000336) | 1.73557990 |
| 100 | Generalized aminoaciduria (HP:0002909) | 1.73528095 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CCNB1 | 7.53171417 |
| 2 | NEK2 | 6.77352825 |
| 3 | CAMK1D | 4.78110677 |
| 4 | CAMKK2 | 4.77478588 |
| 5 | CAMK1G | 3.16506372 |
| 6 | ERN1 | 3.05262877 |
| 7 | SMG1 | 2.53453905 |
| 8 | TAF1 | 2.44168821 |
| 9 | VRK2 | 2.27143862 |
| 10 | TIE1 | 2.07320122 |
| 11 | CAMK1 | 2.04281276 |
| 12 | PRKAA2 | 1.88291077 |
| 13 | EPHB2 | 1.87983828 |
| 14 | TRIB3 | 1.83747012 |
| 15 | MAP3K7 | 1.78526148 |
| 16 | WNK4 | 1.73417194 |
| 17 | MYLK | 1.71152233 |
| 18 | LRRK2 | 1.68219567 |
| 19 | CAMKK1 | 1.56621695 |
| 20 | TTN | 1.46287155 |
| 21 | TESK1 | 1.37307816 |
| 22 | OBSCN | 1.35040130 |
| 23 | GRK5 | 1.13243294 |
| 24 | CHUK | 1.13099388 |
| 25 | RIPK1 | 1.11782326 |
| 26 | EPHA3 | 1.05261122 |
| 27 | MAPK4 | 1.03857977 |
| 28 | TGFBR2 | 1.02676145 |
| 29 | PRPF4B | 0.94710217 |
| 30 | ICK | 0.87703426 |
| 31 | DDR2 | 0.87562951 |
| 32 | MARK2 | 0.83365884 |
| 33 | ABL2 | 0.81929768 |
| 34 | PDGFRB | 0.81429987 |
| 35 | MAPKAPK5 | 0.78535378 |
| 36 | NEK9 | 0.77318288 |
| 37 | PRKAA1 | 0.73763012 |
| 38 | CAMK4 | 0.71756078 |
| 39 | TESK2 | 0.70456406 |
| 40 | PAK2 | 0.67005237 |
| 41 | FGFR4 | 0.65409982 |
| 42 | PRKD1 | 0.63175457 |
| 43 | WNK1 | 0.59234170 |
| 44 | HIPK2 | 0.57114701 |
| 45 | SIK1 | 0.55461624 |
| 46 | PDGFRA | 0.55375485 |
| 47 | CSK | 0.53530295 |
| 48 | IRAK3 | 0.52676998 |
| 49 | PDPK1 | 0.49985879 |
| 50 | TYRO3 | 0.46572490 |
| 51 | GRK1 | 0.44684236 |
| 52 | DAPK3 | 0.44619280 |
| 53 | LATS2 | 0.42529767 |
| 54 | CDK9 | 0.42425769 |
| 55 | MAP3K6 | 0.39565501 |
| 56 | TRPM7 | 0.38689224 |
| 57 | PAK4 | 0.37407101 |
| 58 | PIK3CA | 0.36612639 |
| 59 | LIMK1 | 0.36171914 |
| 60 | PHKG2 | 0.36106088 |
| 61 | PHKG1 | 0.36106088 |
| 62 | GSK3A | 0.35694329 |
| 63 | MAP3K3 | 0.35134691 |
| 64 | PRKG1 | 0.33784643 |
| 65 | DYRK1A | 0.33414969 |
| 66 | EPHB1 | 0.32783059 |
| 67 | PRKACG | 0.32317654 |
| 68 | CDC42BPA | 0.29078361 |
| 69 | PTK2B | 0.27165886 |
| 70 | MELK | 0.26845440 |
| 71 | SGK2 | 0.25164131 |
| 72 | MAPK12 | 0.25039468 |
| 73 | FGFR3 | 0.24347781 |
| 74 | MAP2K1 | 0.22528617 |
| 75 | LMTK2 | 0.22064417 |
| 76 | CAMK2D | 0.21587911 |
| 77 | MTOR | 0.21214052 |
| 78 | NUAK1 | 0.20680971 |
| 79 | FER | 0.20454981 |
| 80 | PTK2 | 0.19983943 |
| 81 | EIF2AK2 | 0.19980091 |
| 82 | SGK223 | 0.19503813 |
| 83 | SGK494 | 0.19503813 |
| 84 | IGF1R | 0.19161304 |
| 85 | ERBB4 | 0.18530193 |
| 86 | MOS | 0.18307278 |
| 87 | PRKACA | 0.16031887 |
| 88 | RPS6KA3 | 0.15030173 |
| 89 | PDK1 | 0.13512832 |
| 90 | PDK2 | 0.13416231 |
| 91 | PKN1 | 0.13378704 |
| 92 | PRKCE | 0.12971996 |
| 93 | PRKACB | 0.12770099 |
| 94 | PIK3CG | 0.12706515 |
| 95 | PAK3 | 0.11530029 |
| 96 | MAPKAPK3 | 0.09952970 |
| 97 | SGK3 | 0.09009967 |
| 98 | DYRK3 | 0.08886869 |
| 99 | ADRBK1 | 0.08780741 |
| 100 | AKT1 | 0.08630942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.63038320 |
| 2 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.36814969 |
| 3 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 3.17327438 |
| 4 | Pyruvate metabolism_Homo sapiens_hsa00620 | 3.05672205 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.96689285 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.75459024 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.73744380 |
| 8 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.64050048 |
| 9 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.39841509 |
| 10 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.32090752 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.27129150 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.24838120 |
| 13 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.15276669 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.10120915 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.07155855 |
| 16 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.05236504 |
| 17 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.01169257 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.01099669 |
| 19 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.97505301 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.94037735 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.92616205 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.92019474 |
| 23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.87376022 |
| 24 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.86872663 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.83549233 |
| 26 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.78751875 |
| 27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.62956282 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61497851 |
| 29 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.59145986 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.57908300 |
| 31 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.54268854 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.43424558 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.37879150 |
| 34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.37225186 |
| 35 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.34801484 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33431945 |
| 37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.33214554 |
| 38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.31745953 |
| 39 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.29548174 |
| 40 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.27198903 |
| 41 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.22736022 |
| 42 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.14834275 |
| 43 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.14226840 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12634718 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.10361324 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.05724415 |
| 47 | Peroxisome_Homo sapiens_hsa04146 | 1.04528401 |
| 48 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.97664095 |
| 49 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.92792338 |
| 50 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.91446081 |
| 51 | Bile secretion_Homo sapiens_hsa04976 | 0.87907489 |
| 52 | Lysine degradation_Homo sapiens_hsa00310 | 0.87058005 |
| 53 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82056348 |
| 54 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.80667099 |
| 55 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72767671 |
| 56 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.68659263 |
| 57 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65803764 |
| 58 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63406637 |
| 59 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.61637546 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60468566 |
| 61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59155901 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59026138 |
| 63 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56109463 |
| 64 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.55882295 |
| 65 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.51819321 |
| 66 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50677612 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 0.48026493 |
| 68 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.45756673 |
| 69 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.44087828 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43669119 |
| 71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.43067070 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.42066639 |
| 73 | Focal adhesion_Homo sapiens_hsa04510 | 0.41614636 |
| 74 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41097406 |
| 75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.40258775 |
| 76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38137163 |
| 77 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.37252932 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34045275 |
| 79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.32109645 |
| 80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31231714 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.28773534 |
| 82 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.25367362 |
| 83 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24308170 |
| 84 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.24207360 |
| 85 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.22908665 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.22372496 |
| 87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21223842 |
| 88 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.17843531 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.13884131 |
| 90 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.13718236 |
| 91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.09836360 |
| 92 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.09031296 |
| 93 | Lysosome_Homo sapiens_hsa04142 | 0.04351519 |
| 94 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.04098909 |
| 95 | Axon guidance_Homo sapiens_hsa04360 | 0.02999475 |
| 96 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.02496268 |
| 97 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.01247482 |
| 98 | Cocaine addiction_Homo sapiens_hsa05030 | 0.01148412 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.00944818 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.00304579 |

